12122172

Source:http://linkedlifedata.com/resource/pubmed/id/12122172

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0015980, umls-concept:C0016441, umls-concept:C0022877, umls-concept:C0026769, umls-concept:C0030705, umls-concept:C0085862, umls-concept:C0443199, umls-concept:C0475463, umls-concept:C1280500, umls-concept:C1299583, umls-concept:C1549571, umls-concept:C1608386
pubmed:issue	2
pubmed:dateCreated	2002-7-17
pubmed:abstractText	To evaluate the incidence and the prevalence of neutralising antibodies (NABs) to three interferon beta (IFNbeta) products in patients with multiple sclerosis (MS).
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-10214750, http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-10526196, http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-10534242, http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-10809912, http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-10936507, http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-11006365, http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-11079533, http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-11094118, http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-12122161, http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-2429157, http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-6685237, http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-6847134, http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-8301153, http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-8602746, http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-8649563, http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-8780061, http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-9287241, http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-9305316, http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-9587963, http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-9595973, http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-9620362, http://linkedlifedata.com/resource/pubmed/commentcorrection/12122172-9726446
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2985191R
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-beta, http://linkedlifedata.com/resource/pubmed/chemical/interferon beta 1a, http://linkedlifedata.com/resource/pubmed/chemical/interferon beta-1b
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	0022-3050
pubmed:author	pubmed-author:BertolottoAA, pubmed-author:CapobiancoMM, pubmed-author:CarrieriP BPB, pubmed-author:GiordanaM TMT, pubmed-author:MalucchiSS, pubmed-author:MelinAA, pubmed-author:MilanoEE, pubmed-author:OreficeGG, pubmed-author:SalaAA
pubmed:issnType	Print
pubmed:volume	73
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	148-53
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:12122172-Adult, pubmed-meshheading:12122172-Antibodies, pubmed-meshheading:12122172-Antibody Specificity, pubmed-meshheading:12122172-Drug Administration Schedule, pubmed-meshheading:12122172-Female, pubmed-meshheading:12122172-Humans, pubmed-meshheading:12122172-Injections, Intramuscular, pubmed-meshheading:12122172-Injections, Subcutaneous, pubmed-meshheading:12122172-Interferon-beta, pubmed-meshheading:12122172-Male, pubmed-meshheading:12122172-Middle Aged, pubmed-meshheading:12122172-Multiple Sclerosis, pubmed-meshheading:12122172-Neutralization Tests
pubmed:year	2002
pubmed:articleTitle	Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory.
pubmed:affiliation	Centro di Riferimento Regionale Sclerosi Multipla & Laboratorio di Neurobiologia Clinica, Divisione Universitaria di Neurologia, Azienda Ospedaliera S Luigi, Università di Torino, Orbassano, Italy. nsglb@tin.it
pubmed:publicationType	Journal Article, Comparative Study, Research Support, Non-U.S. Gov't